Non-coding RNAs in disease: from mechanisms to therapeutics

被引:248
|
作者
Nemeth, Kinga [1 ]
Bayraktar, Recep [1 ]
Ferracin, Manuela [2 ,3 ]
Calin, George A. [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol Dept, Houston, TX 77030 USA
[2] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Bologna, Italy
[4] Univ Texas MD Anderson Canc Ctr, RNA Interference & Noncoding RNA Ctr, Houston, TX 77030 USA
关键词
CORONARY-ARTERY-DISEASE; CIRCULAR RNAS; PROGNOSTIC BIOMARKER; TRANSCRIPTION FACTOR; PROFILING REVEALS; PERIPHERAL-BLOOD; DOWN-REGULATION; POOR-PROGNOSIS; HEART-FAILURE; CELL-CYCLE;
D O I
10.1038/s41576-023-00662-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-coding RNAs (ncRNAs) are a heterogeneous group of transcripts that, by definition, are not translated into proteins. Since their discovery, ncRNAs have emerged as important regulators of multiple biological functions across a range of cell types and tissues, and their dysregulation has been implicated in disease. Notably, much research has focused on the link between microRNAs (miRNAs) and human cancers, although other ncRNAs, such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are also emerging as relevant contributors to human disease. In this Review, we summarize our current understanding of the roles of miRNAs, lncRNAs and circRNAs in cancer and other major human diseases, notably cardiovascular, neurological and infectious diseases. Further, we discuss the potential use of ncRNAs as biomarkers of disease and as therapeutic targets. In this Review, the authors describe our current knowledge of the role of microRNAs, long non-coding RNAs and circular RNAs in disease, with a focus on cardiovascular, neurological, infectious diseases and cancer. Further, they discuss the potential use of non-coding RNAs as disease biomarkers and as therapeutic targets.
引用
收藏
页码:211 / 232
页数:22
相关论文
共 50 条
  • [1] Non-coding RNAs in disease: from mechanisms to therapeutics
    Kinga Nemeth
    Recep Bayraktar
    Manuela Ferracin
    George A. Calin
    Nature Reviews Genetics, 2024, 25 : 211 - 232
  • [2] Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
    Xu, Suowen
    Kamato, Danielle
    Little, Peter J.
    Nakagawa, Shinichi
    Pelisek, Jaroslav
    Jin, Zheng Gen
    PHARMACOLOGY & THERAPEUTICS, 2019, 196 : 15 - 43
  • [3] Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics
    Chen, Jinhong
    Liu, Zhichao
    Ma, Li
    Gao, Shengwei
    Fu, Huanjie
    Wang, Can
    Lu, Anmin
    Wang, Baohe
    Gu, Xufang
    FRONTIERS IN GENETICS, 2021, 12
  • [4] Small Non-Coding RNAs as Novel Therapeutics
    Rossbach, M.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (04) : 361 - 368
  • [5] Long non-coding RNAs in development and disease: conservation to mechanisms
    Tsagakis, Ioannis
    Douka, Katerina
    Birds, Isabel
    Aspden, Julie L.
    JOURNAL OF PATHOLOGY, 2020, 250 (05): : 480 - 495
  • [6] Non-coding RNAs in stroke pathology, diagnostics, and therapeutics
    Potemkin, Nikita
    Clarkson, Andrew N.
    NEUROCHEMISTRY INTERNATIONAL, 2023, 162
  • [7] Non-coding RNAs and the advent of new directions in therapeutics
    Glorioso, J. C.
    GENE THERAPY, 2011, 18 (12) : 1103 - 1103
  • [8] Non-coding RNAs and the advent of new directions in therapeutics
    J C Glorioso
    Gene Therapy, 2011, 18 : 1103 - 1103
  • [9] Non-coding RNAs in human disease
    Esteller, Manel
    NATURE REVIEWS GENETICS, 2011, 12 (12) : 861 - 874
  • [10] Non-coding RNAs: regulators of disease
    Taft, Ryan J.
    Pang, Ken C.
    Mercer, Timothy R.
    Dinger, Marcel
    Mattick, John S.
    JOURNAL OF PATHOLOGY, 2010, 220 (02): : 126 - 139